BLTE

Belite Bio Inc ADR is a clinical-stage biopharmaceutical company based in San Diego, California, specializing in the development of innovative therapies for ocular disorders, particularly age-related atrophic macular degeneration and autosomal recessive Stargardt disease. The company is dedicated to addressing critical unmet medical needs within the ophthalmic field by advancing its proprietary drug candidates through extensive clinical trials. With a focus on cutting-edge research and transformative treatment solutions, Belite Bio is strategically positioned to make significant contributions to the evolving landscape of ophthalmology and improve patient outcomes.